Grant: Discovery Grants Program - Individual
University of Alberta
$100,000.00
Natural product synthesis and development of synthetic methodology
FY 2012-13
Summary
The research proposal deals with (1) plans for the total synthesis of several biologically important and complex natural products and with the development of new synthetic methodology to deal with the constructional problems posed by these compounds, and (2) the development of general synthetic methods that should have wide applicability to a range of target substances. The main natural products are (1) CP-225,917, an anticancer and cholesterol-lowering substance; (2) marinopyrrole B, an unprecedented class of antibiotic; (3) coleophomone B, an inhibitor of an enzyme involved in bacterial cell wall synthesis; (4) sorbicillactone A, which shows selective anti-leukemic activity, and also has antiviral (HIV) and neuroprotective properties; and (5) MPC1001, which exhibits very powerful activity against a prostate cancer cell line. These natural products, besides having biological properties that identify them as important synthetic targets, also pose constructional problems that are of general occurrence and the solution to these problems will fill gaps in current technology. In relation to these target molecules, new routes to pyrroles, macrolactams and tricarbonyl compounds will be studied.
) In the area of general methodology I plan to greatly expand the process of intramolecular conjugate displacement (ICD) so that it affords benzo-fused carbocycles and benzo-fused nitrogen heterocycles as single enantiomers; such substances are of considerable value as privileged structures in the pharmaceutical industry and as subunits for complex molecule synthesis. The ICD process will also be developed to fit into a tandem sequence that serves to assemble several rings in a single operation and a version of the ICD reaction will be examined that gives biologically important bicyclic amides. The possibility of effecting radical reactions without stannanes or silanes will be examined.
Program
Discovery Grants Program - Individual
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
17-2011
Name nom
Clive, Derrick
Department département
Chemistry
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2011
Award amount
100000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
2
Nb partie
5
Application title
Natural product synthesis and development of synthetic methodology
Keyword
NSERC
Application summary
The research proposal deals with (1) plans for the total synthesis of several biologically important and complex natural products and with the development of new synthetic methodology to deal with the constructional problems posed by these compounds, and (2) the development of general synthetic methods that should have wide applicability to a range of target substances. The main natural products are (1) CP-225,917, an anticancer and cholesterol-lowering substance; (2) marinopyrrole B, an unprecedented class of antibiotic; (3) coleophomone B, an inhibitor of an enzyme involved in bacterial cell wall synthesis; (4) sorbicillactone A, which shows selective anti-leukemic activity, and also has antiviral (HIV) and neuroprotective properties; and (5) MPC1001, which exhibits very powerful activity against a prostate cancer cell line. These natural products, besides having biological properties that identify them as important synthetic targets, also pose constructional problems that are of general occurrence and the solution to these problems will fill gaps in current technology. In relation to these target molecules, new routes to pyrroles, macrolactams and tricarbonyl compounds will be studied.
) In the area of general methodology I plan to greatly expand the process of intramolecular conjugate displacement (ICD) so that it affords benzo-fused carbocycles and benzo-fused nitrogen heterocycles as single enantiomers; such substances are of considerable value as privileged structures in the pharmaceutical industry and as subunits for complex molecule synthesis. The ICD process will also be developed to fit into a tandem sequence that serves to assemble several rings in a single operation and a version of the ICD reaction will be examined that gives biologically important bicyclic amides. The possibility of effecting radical reactions without stannanes or silanes will be examined.